top of page
CODE_02.png

Code Pharma   

Code Pharma is a global pharmaceutical company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections such as HIV-AIDS and Cancer research. We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status. Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.

Antiviral drug Gammora

Code Pharma is the developer of the promising potential cure Gammora for HIV. Gammora is a short synthetic 16 amino-acid peptide, derived from the HIV-1 integrase, originally discovered at the Hebrew University in Israel.

Code Pharma's team investigate the peptide in in-vitro studies, animals models and clinical studies to ensure the safety and efficacy of the peptide. In parallel, drug development studies and investigations were made to deliver the drug with patient compliance.

Clinical studies

Gammora is a short synthetic peptide derived from HIV virus that was found in preclinical and clinical examinations to either:

​​

1. Promote HIV-infected cells into self-induced death (apoptosis), and Lentivirus         manipulation in the case of cancer therapy.

2. Leads to antiviral effect against RNA viruses.

image2.png
to Services

Our Partners

Artboard 1 copy 3.png
Artboard 1.png
Artboard 1 copy.png
Artboard 1 copy 2.png

    Contact    

Thanks for submitting!

bottom of page